Abbott begins new Intravascular Lithotripsy trial to improve outcomes in Coronary Artery Disease patients Ruchika Sharma25 March 2025 2:30 PM ISTAbbott Park: Abbott has announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) for its...
Abbott India Namita Shah - Associate Director - New Product Introduction and Therapy Area Strategy to step down Ruchika Sharma22 Feb 2025 12:30 PM ISTMumbai: Abbott India has announced that Namita Shah - Associate Director - New Product Introduction and Therapy Area Strategy, has tendered her...
Abbott agrees to global continuous glucose monitoring litigation settlement with Dexcom Ruchika Sharma25 Dec 2024 2:11 PM ISTAbbott Park: Abbott has announced it has reached an agreement with DexCom, Inc. to settle all outstanding patent disputes between the...
Abbott initiates new clinical trial to improve outcomes in patients with advanced Heart Failure Ruchika Sharma31 Oct 2024 2:00 PM ISTAbbott Park, Ill.: Abbott has announced a new, first-of-its-kind clinical trial designed to improve outcomes in patients with worsening heart...
Dexcom Beats Quarterly Sales Expectations, Reaffirms Annual Outlook MD Bureau27 Oct 2024 10:00 AM ISTAnalysts had raised concerns about the pace at which Dexcom was capturing "basal only" diabetes patients who take one insulin injection a day
First trial against Abbott over premature infant formula commences in Missouri Ruchika Sharma11 July 2024 4:00 PM ISTIn a legal battle, the first trial against Abbott, the maker of Similac baby formula, commenced on Tuesday amidst allegations that its formula for...
Abbott gets USFDA clearance for 2 new OTC continuous Glucose monitoring system Ruchika Sharma11 Jun 2024 12:30 PM ISTAbbott Park, Ill.: Abbott has announced U.S. Food and Drug Administration (FDA) clearance for two new over-the-counter continuous glucose...
Aveir DR: Abbott gets CE mark for Dual chamber leadless pacemaker system Ruchika Sharma9 Jun 2024 10:00 AM ISTAbbott Park, Ill.: Abbott has announced the Company has received CE Mark in Europe for the AVEIR dual chamber (DR) leadless pacemaker system, a dual...
Abbott gets USFDA approval for TriClip TEER System for Tricuspid Regurgitation Ruchika Sharma3 April 2024 11:46 AM ISTAbbott Park, III.: Abbott has announced that the U.S. Food and Drug Administration (FDA) has approved the company's first-of-its-kind TriClip...
Abbott gets USFDA clearance for whole blood rapid test to help with assessment of concussion at patient bedside Ruchika Sharma2 April 2024 5:30 PM ISTWith this clearance, the i-STAT TBI test can be used to help evaluate patients up to 24 hours after injury, an advancement since those injured often...
No new concerns raised by USFDA staff about Abbott heart device Ruchika Sharma10 Feb 2024 4:11 PM ISTThe device, already approved in more than 50 countries, is inserted through the femoral vein in the leg and is then guided and clipped on to the...
Abbott India profit rises in Q3 on strong demand Ruchika Sharma2 Feb 2024 10:00 AM ISTBengaluru: Pharmaceutical firm Abbott India reported a 26 percent rise in third-quarter profit on Thursday, as higher sales outpaced the impact...
